Andrew Gaudin 12-month prescription mitigation We have worked intensely with key senior officials to resolve this issue since the government’s policy decision in May 2025. This has included working with officials at multiple levels and providing r... 12-month prescriptions Advocacy Funding NAAR Nov 30, 2025
Kesh Naidoo-Rauf Sector workforce challenges New Zealand, like many countries, is facing a chronic pharmacy workforce shortage. This comes at a time when we are being asked to do more to relieve pressure from our general practice and hospital co... Advocacy Funding Workforce Oct 31, 2025
Andrew Gaudin NAAR process concerns Every year, the NAAR process is expected to be completed before 1 July, with any variations to the ICPSA from NAAR to be agreed by Voluntary Variation between ICPSA providers and HNZ. In 2024 and 2025... Advocacy Funding NAAR Oct 31, 2025
Andrew Gaudin HNZ’s application of cost pressures Budget 2024 was the first time the government agreed to a three-year cost pressures package. Funded cost pressure increases from this package for delivering all primary, community, public and populati... Advocacy Funding NAAR Sep 30, 2025
Nicole Rickman Media release: Guild’s work outside of NAAR delivers for community pharmacy The Pharmacy Guild of New Zealand (the Guild) has successfully secured improvements to the next Integrated Community Pharmacy Services Agreement (ICPSA) voluntary variation by working outside the limi... Advocacy Funding Media release NAAR Sep 14, 2025
Andrew Gaudin Key wins delivered by Guild's advocacy Our advocacy approach is delivered through objectiveanalysis, expert advice and working closely withkey decision-makers. Our approach is always fair,consistent and solutions focused. Our key achieveme... Advocacy Co-payment Funding Aug 31, 2025
Andrew Gaudin NAAR process challenges in 2025 The NAAR process follows the highly flawed Health New Zealand (HNZ) approach to the recognition of reasonable cost pressure adjustments for the 2024/25 process. Every year there is an ICPSA contractua... Advocacy Funding NAAR Jul 31, 2025
Kesh Naidoo-Rauf Meeting with the Minister of Health In May, we had the opportunity to meet with the Minister of Health, Hon Simeon Brown, our first meeting since his appointment in January. We aimed to continue our close, positive, trusted working rela... Advocacy CPLF Funding NAAR Workforce Jun 30, 2025
Andrew Gaudin Decision to allow 12-month prescriptions The Guild first became aware of this policy proposal in October 2024, when we provided significant feedback on the impacts for patients, community pharmacies and the broader healthcare system. Some of... 12-month prescriptions Advocacy Funding Jun 30, 2025
Andrew Gaudin Understanding the 2024/25 funding uplift The ICPSA requires that, before 1 July each year, community pharmacy providers/provider representatives and HNZ acknowledge that each national annual agreement review (NAAR) round will consider reason... Advocacy Funding NAAR May 31, 2025
Nicole Rickman Media release: Guild escalates concerns with HNZ’s 2024 cost pressure uplift The Pharmacy Guild of New Zealand (the Guild) wrote to Health New Zealand (HNZ) last month on behalf of members escalating our significant concerns with HNZ’s approach to the funding of reasonable cos... Advocacy Funding Media release NAAR May 13, 2025
Kesh Naidoo-Rauf Scope of practice increases 2023 minor health conditions service (MHCS) pilot A MHCS was piloted in 10 of 20 districts in New Zealand from June to September 2023, to reduce demand on general practice, urgent care, and hospital e... Advocacy Funding Workforce Apr 30, 2025